COMPUTRON INC. CASE I. Problem Identification: What bid price should Computron Inc. set‚ so that the Computron can achieve management’s profits target‚ match the customer’s requirement and be competitive with respect to the competitors? II. Alternatives: 1) Bid Price: $ 746‚880.00 within 20% offered by Digitex pricing of $ 622‚400. - Will sell less than factory cost of $ 768‚000‚ hence no profit and reduces cash flow required for future investments. - Computron will lose premium quality
Premium Competition Price Marketing
EXPORT‚ LICENSING & FDI a) Export: Exporting involves producing goods at home and then shipping them to the receiving country for sale. Pros: 1) It is a relatively low-cost activity to get involved in international business and expand profit. 2) A firm can further create economies of scale which should lead to lower cost and hence expansion of profit Cons: 1) In relation to location economies‚ a firm may not always be located in the best region for that specific area and is therefore restricted
Premium License Royalties Investment
ESSAY The Licensing in Fashion Industries. 1.1 What is the meaning of licensing agreement? The verb to license is synonymous of give permission. A licensing agreement is an authorization to use licensed material granted by a party named: Licensor to another party called: Licensee. This is a contract between this two parties. The purpose of a licensing agreement is the authorized use of the licensor’s trademark‚ by the licensee‚ specified in the terms of the contract. We know two different
Premium License
Merck‚ being on one of the biggest pharmaceutical companies in the world today‚ came from a meek beginning and still encounters many problems today while trying to maintain a lead amongst its competition. While being looked at as a research and development driven company‚ Merck now has to go beyond R&D to stay competitive in the pharmaceutical industry. Attracting talent to work for the company has never been a problem for Merck‚ but the bigger question was whether or not this talent would be able
Premium Pharmaceutical industry Pharmacology Generic drug
Licensing and The Public Relations Professional: (Will They Ever Be Card Carrying Members?) PR’s Pioneers The public relations field has the opportunity to connect its past and present to garner a powerful future‚ by making the PR profession a licensed one. Since the time of such PR pioneers like Edward Bernays (1891 - 1995)‚ argued to be the "father of public relations" and Ivy Lee (1877 1934) also argued to be the "father of public relations‚ PR practitioners have desperately
Premium Public relations
Professor Kirkpatrick English 102 December 19‚ 2012 Parental Licensing Child abuse or child neglect related incidences on average result in four deaths per day in the United States (Child Welfare‚ 2012). This is an alarming fact that has poisoned our communities and crippled the belief that our country is a safe environment for our children‚ the future leaders of our nation. Are there possibilities to prevent these horrible crimes on innocent children? In California‚ interior
Free Child abuse Neglect Parent
Merck & Co.‚ Inc (A) (The summary is based on the article in Vol. I and does not include the extra readings given by the professor) This case is a classic example of enterprises trying to balance their business of increasing profits and expected social responsibilities. This dilemma is further accentuated when the company happens to be a pharma company whose decisions directly affect people’s lives. The Dilemma: A possible drug for River Blindness‚ a disease which affects almost 85 million
Premium Pharmacology Medicine Affect
Evaluating Merck & Co.‚ Inc vs. Pfizer‚ Inc. Amy Lan Lan Liu Connor Buestad Raghul Subramanian Natalia Cosa ACCT 831 March 16‚ 2011 Table of Contents: Part 1: History‚ Background and Core Business …...................................................................2 a. Merck & Co.‚ Inc. ….............................................................................................................. 2 b. Pfizer
Premium Pharmaceutical industry Pharmacology Generic drug
| Merck & Company Inc. | Case 1 | | | Introduction of the Company Merck was established in 1891 to improve human and animal health through the development of innovative products. Merck currently has two reportable segments‚ the Pharmaceutical Segment and the Vaccines and Infectious Diseases Segment. Merck sells products through several channels including wholesalers‚ retailers‚ hospitals‚ clinics‚ government and managed health services providers. In the 1980’s the Merck was very
Premium Generic drug Pharmaceutical industry Mergers and acquisitions
Merck & Co. Executive Summary Case Study Goal The goal of this case study is to examine the current operations of Merck & Co. Inc. and determine areas of potential concern‚ evaluate the effectiveness of the current business model‚ and propose a plan of action to grow Merck & Co. Inc. to be the largest pharmaceutical company in the world. Methods of Analysis This case study will strive to identify areas of concern and opportunity‚ offer solutions‚ and make projections based upon historic data
Premium Financial ratio Financial ratios Strategic management